Cargando…
Polymyxins–Curcumin Combination Antimicrobial Therapy: Safety Implications and Efficacy for Infection Treatment
The emergence of antimicrobial resistance in Gram-negative bacteria poses a huge health challenge. The therapeutic use of polymyxins (i.e., colistin and polymyxin B) is commonplace due to high efficacy and limiting treatment options for multidrug-resistant Gram-negative bacterial infections. Nephrot...
Autores principales: | Dai, Chongshan, Wang, Yang, Sharma, Gaurav, Shen, Jianzhong, Velkov, Tony, Xiao, Xilong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346118/ https://www.ncbi.nlm.nih.gov/pubmed/32526966 http://dx.doi.org/10.3390/antiox9060506 |
Ejemplares similares
-
The Natural Product Curcumin as an Antibacterial Agent: Current Achievements and Problems
por: Dai, Chongshan, et al.
Publicado: (2022) -
Pharmacokinetics and relative bioavailability of an oral amoxicillin-apramycin combination in pigs
por: Dai, Chongshan, et al.
Publicado: (2017) -
Aflatoxin B1 Toxicity and Protective Effects of Curcumin: Molecular Mechanisms and Clinical Implications
por: Dai, Chongshan, et al.
Publicado: (2022) -
Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative Pathogens
por: Tran, Thien B., et al.
Publicado: (2018) -
Chloroquine ameliorates carbon tetrachloride-induced acute liver injury in mice via the concomitant inhibition of inflammation and induction of apoptosis
por: Dai, Chongshan, et al.
Publicado: (2018)